Sign in Subscribe

Health

Providing perspective and contextual insights on the monetary aspects of the Healthcare market within the state of Utah, from medical providers to insurance and from nutraceuticals to medical devices.

NEWS BRIEF: The University of Utah Landed Nearly $700 Million in Research Funding in Fiscal 2024

NEWS BRIEF: The University of Utah Landed Nearly $700 Million in Research Funding in Fiscal 2024

The University of Utah just announced that it garnered nearly $700 million in research funding in fiscal 2024 (ended 30 June 2024). According to the UofU news release announcing the FY 2024 research funding results, the Salt Lake City-based institution secured $691 million in research funding across such disciplines as

Utah-based PACS Group Closes a Secondary Public Offering, Raising ~$101 Million for the Firm, with ~$589 Million Raised by Selling Shareholders

Utah-based PACS Group Closes a Secondary Public Offering, Raising ~$101 Million for the Firm, with ~$589 Million Raised by Selling Shareholders

Since its $450 million IPO on 11 April 2024 that valued the firm at $3.1 billion, Farmington, Utah-based PACS Group (NYSE:PACS) has been on a tear, with its valuation jumping nearly 87% since the IPO to a high of $42.25 two weeks ago. Now PACS has closed

Top 23 Utah-focused Monetary, Financial and/or Business News Nuggets from August 2024 that You Might have Missed

Top 23 Utah-focused Monetary, Financial and/or Business News Nuggets from August 2024 that You Might have Missed

{AUTHOR'S NOTE: Clearly, not every news announcement deserves to be the top story of the day. Nevertheless, many news items are significant and should be acknowledged as such. And in this writeup, you'll find info about 20 Utah-based firms and 18 separate executives that we feel

Yowza — 94 Utah Companies Make the Inc. 5000 List for 2024, with 64 Repeat Honorees

Between them, these 94 Utah-based firms had a 230% median growth rate, while 64 of the 94 firms were repeat honorees.

The Top 11 Utah-focused Monetary, Financial and/or Business News Nuggets from the Second Half of July 2024 that You Might have Missed

The Top 11 Utah-focused Monetary, Financial and/or Business News Nuggets from the Second Half of July 2024 that You Might have Missed

{AUTHOR'S NOTE: Clearly, not every news announcement deserves to be the top story of the day. Nevertheless, many news items are significant and should be acknowledged as such. And in this writeup, you'll find info about 11 Utah-based firms and eight separate executives that we feel

But Wait, There's More: Utah-based Recursion Pharmaceuticals is Acquiring UK-based Exscientia for $688 Million in an All-Stock Deal

But Wait, There's More: Utah-based Recursion Pharmaceuticals is Acquiring UK-based Exscientia for $688 Million in an All-Stock Deal

Early yesterday morning (Thursday, 08 August 2024), Salt Lake City, Utah-based Recursion Pharmaceuticals (NASDAQ:RXRX) announced that is "combining" with Oxford, England-based Exscientia (NASDAQ:EXAI) in an all-stock transaction that will create a global tech-enabled drug-development / drug-discovery powerhouse. Under terms of the agreement disclosed in yesterday's

Creation of the World's First "Neuromap" by Utah-based Recursion Pharmaceuticals Triggers a $30 Million Payment from Roche and Genentech

Creation of the World's First "Neuromap" by Utah-based Recursion Pharmaceuticals Triggers a $30 Million Payment from Roche and Genentech

Recursion breakthrough leads to new type of mapping the brain.